Last reviewed · How we verify
NCT05786365
Comparison of Emergence/Dysphoric Reaction Frequency of Using 2 Different Doses Ketamine
trial testing Ketalar 50 MG/ML Injectable Solution in Sedation Complication in 108 participants. Completed in 31 December 2023.
15 September 2023
Quick facts
| Lead sponsor | Aksaray University Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 108 |
| Start date | 1 January 2023 |
| Primary completion | 15 September 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Ketalar 50 MG/ML Injectable Solution — full drug profile →
Conditions studied
- Sedation Complication — all drugs for Sedation Complication →
Sponsor
Aksaray University Training and Research Hospital
Who can join
Adults 18 to 75, any sex, with Sedation Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to compare the effect of using different doses of ketamine on producing dysphoric reaction.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of the incidence of recovery agitation with two different doses of ketamine in procedural sedation: A randomized clinical trial.
Türkücü Ç, Parlak İ, Kokulu K, Sert ET, et al · · 2025 · cited 3× · PMID 39878430 · DOI 10.1111/acem.15116
Verify or expand the search:
- PubMed search for NCT05786365
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ketalar 50 MG/ML Injectable Solution
Trials testing the same drug.
- NCT05343507 — Ketamine to Treat Patients With Post-comatose Disorders of Consciousness · Phase 2, PHASE3 · recruiting
Other recruiting trials for Sedation Complication
Currently open trials in the same condition.
- NCT06667869 — multipaRameter mOnitoring systeM for sedAtion iNThe ICu · recruiting
- NCT07456111 — A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy · Phase 4 · recruiting
- NCT06769308 — Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients · NA · recruiting
- NCT05371886 — Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal · NA · recruiting
- NCT05765162 — Safe Brain Initiative, Operationalizing Precision Anaesthesia · recruiting
Other Aksaray University Training and Research Hospital trials
Trials by the same sponsor.
- NCT07379879 — Acute Neurochemical and Cognitive Changes After HIIT vs MICT/LICT · NA · completed
- NCT07191015 — Temporal Dynamics of Irisin · NA · completed
- NCT07395765 — Comparing Touch-Limited and Free-Play 4v4 Small-Sided Games (SSGs) · NA · completed
- NCT07137611 — Effects of Different Types of Exercise on BDNF and Cognitive Performance (Exercise-BDNF) · NA · completed
- NCT07146490 — Effects of Different Types of Exercise on Irisin and Cognitive Performance (Exercise-Irisin) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05786365 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aksaray University Training and Research Hospital
- Last refreshed: 30 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05786365.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing